![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 30, 28029-28036, July 27, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶,
,
,
, and
From the
Cardiovascular Biology Laboratory, Harvard School
of Public Health,
Cardiac Unit, Massachusetts General
Hospital, and § Department of Medicine, Harvard Medical
School, Boston, Massachusetts 02115, and ** Abbott Laboratories, Abbott
Park, Illinois 60064
Received for publication, April 23, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Friend of GATA (FOG)-2 is a
multi-zinc finger transcriptional corepressor protein that binds
specifically to GATA4. Gene targeting studies have demonstrated that
FOG-2 is required for normal cardiac morphogenesis, including the
development of the coronary vasculature, left ventricular compact zone,
and heart valves. To better understand the molecular mechanisms by
which FOG-2 regulates these cardiac developmental programs, we screened
a mouse day 11 embryo library using a yeast two-hybrid interaction trap
with the fifth and sixth zinc fingers of FOG-2 as bait. Using this
approach, we isolated clones encoding the orphan nuclear receptors
chicken ovalbumin upstream promoter-transcription factor (COUP-TF) 2 and COUP-TF3. COUP-TF2-null embryos die during embryonic development
with defective angiogenesis and cardiac defects, a pattern that partly
resembles the FOG-2-null phenotype. The interaction between COUP-TF2
and FOG-2 in mammalian cells was confirmed by co-immunoprecipitation of
these proteins from transfected COS-7 cells. The sites of binding interaction between COUP-TF2 and FOG-2 were mapped to zinc fingers 5 and 6 and fingers 7 and 8 of FOG-2 and to the carboxyl terminus of the
COUP-TF proteins. Binding to COUP-TF2 was specific because FOG-2 did
not interact with the ligand-binding domains of retinoid X receptor
Transcriptional cofactors that bind multiple DNA-binding proteins
can broadly affect the transcription of and developmental programs
underlying mammalian organogenesis (1). The nuclear proteins Friend of
GATA (FOG)1-1 and FOG-2 are
multi-zinc finger transcriptional corepressors that bind specifically
to members of the GATA family of transcription factors. FOG-1 is
required for normal erythroid and megakaryocyte development (2-4),
whereas FOG-2 is required for cardiac development (5, 6). Mammalian
FOG-1 and FOG-2 originate from a single ancestral gene represented by
the Drosophila gene Ush. FOG-1/FOG-2/Ush have
both CCHH zinc fingers, commonly regarded as RNA and DNA binding
structures, and a distinct subclass of zinc fingers identified by the
CCHC motif that bind to protein (7). The location and the tertiary
structure of the CCHC fingers within the FOG-1/FOG-2/Ush molecules are
conserved, suggesting that the multiple zinc fingers have distinct
functions that have been retained during evolution (8).
The FOG-1/FOG-2 proteins were first identified by their interaction
with the GATA family of transcription factors, which have two CCCC zinc
fingers (9-11). The GATA carboxyl zinc finger binds the WGATAR DNA
element and transcription factors including the cardiac homeobox
protein Nkx2.5 (12, 13). The amino zinc finger stabilizes DNA binding
and also binds the FOG-1/FOG-2 CCHC zinc fingers (9). Among the FOG-2
CCHC zinc fingers, the GATA proteins bind zinc fingers 1 and 6 strongly
and fingers 5 and 8 weakly but do not bind to finger 7 (8, 14).
Conserved amino acids required for binding have been identified within
the first zinc finger of FOG-1 and the amino zinc finger of GATA (14).
GATA proteins do not bind the FOG-2 CCHH fingers.
FOG-1 is co-expressed with GATA1, GATA2, and GATA3 in hematopoietic
cells (2, 4), whereas FOG-2 is co-expressed with GATA4, GATA5, and
GATA6 in the developing heart (9-11). GATA cis-acting elements in the Na+-Ca2+ exchanger (15),
cardiac troponin C (16), Nkx2.5 (17, 18), and m2 muscarinic
acetylcholine receptor (19) gene promoters are necessary for
cardiac-specific transcription. GATA4-deficient embryos die during
early development with abnormal ventral morphogenesis and failure to
form a linear heart tube (20, 21). Murine FOG-2 is expressed after
GATA4, initially in the septum transversum at embryonic day 8.5 and
later throughout the heart (9-11). Transient transfection assays have
demonstrated that FOG-2 represses activation of numerous
cardiac-specific promoters by GATA4, but not by the cardiac homeobox
protein Nkx2.5 (22).
In Drosophila, Ush is co-expressed in the
cardiogenic mesoderm with the GATA homologue pannier. Loss
of Ush results in overproduction of cardiac and precardiac
cells, whereas Ush overexpression inhibits cardioblast
formation (23). Drosophila cardioblasts harboring hypomorphic and null Ush alleles have impaired cell
migration, whereas embryos transheterozygous for Ush showed
excessive migration. FOG-2-null mice die during embryonic development
with complex cardiac defects including tricuspid atresia, pulmonic
stenosis, atrial septal defect, ventricular septal defect, hypoplasia
of the left ventricular compact zone, and absent coronary vessel formation (5, 6). The complex valvular and septal abnormalities suggest
impaired migration of nonproliferating myocardial cells into the
superior and inferior atrioventricular cushions. In response to
inductive signals from the myocardium, subpopulations of proepicardial and epicardial cells undergo an epithelial-mesenchymal transformation and invade the myocardium to form the coronary vessels. The absent coronary vasculature and tricuspid valve in FOG-2-null embryos likely
reflect the loss of FOG-2-dependent mesenchymal signaling and migration (5, 6).
The molecular mechanism(s) underlying the congenital heart defects seen
in FOG-2-deficient mice is poorly understood. Although these
abnormalities may reflect dysregulation of a purely
GATA-dependent transcriptional program, we hypothesized
that the complex phenotype might alternatively reflect a loss of FOG-2
interaction with additional families of transcription factors. To
address this possibility, we screened a mouse embryonic day 11 library
using a FOG-2 bait in a yeast two-hybrid interaction trap. Using this
approach, we isolated clones encoding the orphan nuclear receptors
COUP-TF2 and COUP-TF3 (24-26). COUP-TF2 is required for development of
the sinus venosus and cardiac atrium beyond a primitive tube, as well as for remodeling of the primitive capillary plexus (27). Like FOG-2,
the cardiovascular abnormalities in COUP-TF2-null embryos demonstrate
an important role of COUP-TF2 in mesenchymal-endothelial and
-epithelial interactions (27). This report details our studies on the
molecular interaction of FOG-2 with COUP-TF2, in which we demonstrate
that FOG-2 can serve as a corepressor protein for COUP-TF2 in addition
to GATA4.
Gene Constructs--
Using oligonucleotide primers, we cloned
nucleotides 1761-2764 of FOG-2 in-frame with the GAL4 DNA-binding
domain cDNA in the pBD-GAL4-CAM (Stratagene) and the pM
(CLONTECH) vectors to produce GAL4-FOG-2(amino acid
(aa) 497-831) fusion proteins. GST-FOG-2 fusion proteins were produced
from pGEX plasmids encoding fragments of FOG-2 from the amino terminus
(aa 31-248), the first four zinc fingers (F1-4, aa 234-399), the
fifth and sixth zinc fingers (F5-6, aa 533-724), the sixth zinc
finger (F6, aa 668-724), and the seventh and eighth zinc fingers
(F7-8, aa 848-1152). Full-length FOG-2 cloned into the
BamHI site of the pcDNA3 vector was used for expression in eukaryotic cells (9). pM-FOG-2(aa 497-831)-C571S (M5F6) and -C692S
(F5M6) were made using site-directed polymerase chain reaction-based
mutagenesis using synthetic oligonucleotide primers (Table
I). pM-FOG-2(aa 497-831)-C571S-C692S
(M5M6) was made by cloning the 3' HindIII fragment from
pM-FOG-2(aa 497-831)-C692S into pM-FOG-2(aa 497-831)-C571S. All
constructs were sequenced using standard techniques.
PACT2-COUP-TF2(aa 117-414) and pACT2-COUP-TF3(162-390) were cloned
from the Mouse 11-day Embryo MATCHMAKER cDNA library
(CLONTECH). Using the oligonucleotide primer
COUP-TF2-ATG (Table I), the 5' end of COUP-TF2 was cloned into the
EcoRI site of pM. The BstX1 restriction digest
fragment of COUP-TF2 was cloned into this vector to create full-length
pM-COUP-TF2(1-414) (full-length COUP-TF plasmids were kindly provided
by W. Kruijer (26)). The BamHI/XhoI fragment of
pACT2-COUP-TF2(aa 117-414) was cloned into pM to make pM-COUP-TF2(117-414). Truncated mutants pM-COUP-TF2(1-335) and pM-COUP-TF2(117-335) were made by removal of the 3' HindIII
fragment. EcoRI/XbaI COUP-TF2 fragments from the
pM plasmids were then cloned into pVP16 to make pVP16-COUP-TF2(1-414),
pVP16-COUP-TF2(117-414), and pVP16-COUP-TF2(117-377). Similar cloning
techniques were used to make pcDNA3.1-His-COUP-TF2 (Invitrogen) for
in vitro transcription/translation and for eukaryotic
expression. The pM- and pVP16-COUP-TF2-(117-414)-L364R-L365S-L367F constructs were produced using the QuikChange Site-directed Mutagenesis Kit (Stratagene) with the COUP-TF-Mut primers (Table I). cDNA coding regions of COUP-TF1 and COUP-TF3, kindly provided by W. Kruijer
(26), were subcloned into pCR3 (Invitrogen) for in vitro transcription and translation.
PACT2-PPAR Yeast Two-hybrid Assay--
A single clone of AH109 harboring
pBD-GAL4-CAM-FOG2(aa 497-831) was expanded and transformed with the
Mouse 11-day Embryo MATCHMAKER cDNA library. Library plasmids from
clones demonstrating histidine and adenine auxotrophy and
Co-immunoprecipitation--
COS-7 cells transfected with
expression plasmids using the Superfect transfection reagent (Qiagen)
were harvested 24-48 h after transfection in radioimmune precipitation
buffer (28) supplemented with the Complete mixture of protease
inhibitors (Roche Molecular Biochemicals). Preimmune or immune rabbit
antisera was mixed with clarified cell extract and radioimmune
precipitation buffer supplemented with 1 mg/ml bovine serum albumin for
at least 1 h, followed by precipitation with protein A-agarose
beads (Roche Molecular Biochemicals). After washing in radioimmune
precipitation buffer three times on ice, proteins were eluted with
sample buffer, subjected to 8% SDS-polyacrylamide gel electrophoresis,
and blotted onto nitrocellulose. The membrane was then divided, and the
upper half was probed with dilute FOG-2 antisera, and the lower half was probed with anti-X-press (Invitrogen) followed by anti-rabbit or
anti-mouse IgG-horseradish peroxidase. The chemiluminescent image was developed on Kodak BioMax MR film.
GST Pull-down Assay--
Recombinant COUP-TF1, COUP-TF2,
COUP-TF3, RXR Transfection--
NIH 3T3, COS-7, and CV-1 cells were cultured
in Dulbecco's modified Eagle's medium supplemented with 10% fetal
bovine serum (Summit, Fort Collins, CO), 100 units/ml penicillin, and
100 µg/ml streptomycin in a humidified atmosphere at 37 °C with
5% CO2. 293 cells were cultured in the same medium
supplemented with 20 mM HEPES and 1 mM
nonessential amino acids. Transient transfection assays were performed
in 12- or 24-well dishes with 50 ng of reporter plasmid, and a
total of 225 ng of expression plasmid and 25 ng of cytomegalovirus
Statistical Analysis--
The mean and standard error of the
mean were determined for replicate samples. For multiple treatment
groups, a factorial analysis of variance was applied followed by
Fisher's least significant difference test. A p value of
less than 0.05 was considered significant.
Cloning of COUP-TF2 and COUP-TF3 by Yeast Two-hybrid Library
Screen--
Using the fifth and sixth zinc fingers of FOG-2 as bait,
we screened 1.2 million clones of a mouse embryonic day 11 library for
novel interacting partners. Twenty-four clones demonstrated histidine
and adenine auxotrophy and
The interaction of FOG-2 and COUP-TF2 was confirmed in mammalian cells
by co-immunoprecipitation. COS-7 cells transfected with
pcDNA3-FOG-2 expressed full-length FOG-2, which was
immunoprecipitated by immune (I) FOG-2 antisera (Fig.
1B, lanes 2 and 6). X-press epitope-tagged COUP-TF2 was not immunoprecipitated by FOG-2 antisera (lane 4), rather, COUP-TF2 was only isolated after
co-immunoprecipitation with FOG-2 (lane 6).
COUP-TF2 Interacts with Multiple FOG-2 Zinc Fingers--
To assess
the relative binding of COUP-TF2 with the zinc fingers of FOG-2, we
performed an in vitro binding assay with GST-FOG-2 fusion
proteins. The COUP-TF2 in vitro translation product was selectively retained by GST-FOG-2 fusion proteins including the seventh
and eight (F7-8) and the fifth and sixth (F5-6) zinc fingers to a
greater extent than the sixth zinc finger (F6) or the first four zinc
fingers (F1-4). COUP-TF2 was not retained by the fingerless amino
terminus of FOG-2 or by GST alone (Fig.
2, top panel). This binding
pattern differed from that of GATA4, which interacted equally well with
all of the GST-FOG-2 fusion proteins containing zinc fingers (Fig. 2,
middle panel). The most notable difference was the weak
interaction of COUP-TF2 with zinc finger 6, whereas GATA4 interacted
strongly with zinc finger 6. GST-FOG-2 fusion proteins did not
retain [35S]methionine-labeled luciferase (Fig. 2,
bottom panel).
Interaction of COUP-TF2 with FOG-2 is Zinc
Finger-dependent--
Because COUP-TF2 bound GST-FOG-2
fusion proteins containing zinc fingers, we hypothesized that this
interaction required intact FOG-2 zinc fingers. In the mammalian
two-hybrid system, the fifth and sixth zinc fingers of FOG-2(aa
497-831) (F5F6) fused to the GAL4 DNA-binding domain were tested for
their ability to interact with COUP-TF2(117-414) fused to the VP16
transcriptional activation domain. Interaction of COUP-TF2(117-414)
with F5F6 is demonstrated by an almost 4-fold activation of luciferase
activity compared with GAL4 (Fig. 3).
Next, plasmids encoding GAL4-FOG-2 cysteine-to-serine mutations
selectively disrupting the fifth zinc finger (M5F6), sixth zinc finger
(F5M6), and both the fifth and sixth zinc fingers (M5M6) were tested
for interaction with VP16-COUP-TF2(117-414). Western blotting
confirmed expression of each GAL4 fusion protein (data not shown).
Mutation of the fifth zinc finger reduced the interaction of
VP16-COUP-TF2(117-414) with GAL4-FOG-2(aa 497-831) by almost half,
whereas mutation of finger 6 had less of an effect (Fig. 3). Mutation
of both FOG-2 fingers 5 and 6 abolished the interaction. This finding
demonstrates that FOG-2 zinc fingers are necessary for interaction with
COUP-TF2.
FOG-2 Interacts with the Carboxyl Terminus of COUP-TF2--
We
used the mammalian two-hybrid assay to further characterize the
interaction of FOG-2 and COUP-TF2 in NIH 3T3 cells. GAL4-FOG-2(aa 497-831) significantly bound VP16-COUP-TF2(1-414) and
VP16-COUP-TF2(117-414) (Fig. 4), whereas
there was no interaction with VP16-COUP-TF2(1-335) or
VP16-COUP-TF2(117-335). The carboxyl terminus of nuclear hormone receptors is required for ligand binding, dimerization, and interaction with corepressor and coactivator proteins (29). Crystallography has
demonstrated that the tenth (H10) of 12 helices is required for
dimerization and protein-protein interaction (30). Previous work has
demonstrated that the introduction of three amino acid substitutions in
H10 of COUP-TF2 greatly reduces DNA binding and repression activity
(31). We reproduced the same mutations in VP16-COUP-TF2(117-414)-L363R-L364S-L367F (117-414 MUT) to
test our hypothesis that H10 is required for FOG-2 interaction.
VP16-COUP-TF2(117-414 MUT) did not interact with the fifth and sixth
fingers of FOG-2, which further localizes the site of FOG-2 interaction
within the COUP-TF2 ligand-binding domain.
FOG-2 Interacts Specifically with COUP-TF1, COUP-TF2, and
COUP-TF3--
In the absence of ligand, nuclear hormone receptors
partner with specific corepressor proteins, which repress transcription (1). We performed in vitro binding assays with
GST-FOG-2-F5-6 fusion protein to determine the specificity of
interaction between FOG-2 and members of the COUP-TF and nuclear
hormone family of proteins. The in vitro translation
products of full-length GATA4, COUP-TF1, and COUP-TF3, but not those of
RXR FOG-2 Enhances Repression Mediated by GAL4-COUP-TF2--
Because
FOG-2 interacted with the COUP-TF2 repression domain, we hypothesized
that COUP-TF2 may utilize FOG-2 as a corepressor protein. To prove this
hypothesis, we fused fragments of COUP-TF2 to the GAL4 DNA-binding
domain and tested their ability to repress transcription of a
GAL4-responsive SV40 promoter luciferase reporter plasmid (kindly
provided by M. Lazar (32)) in the presence or absence of FOG-2.
Co-expression of FOG-2 with GAL4 did not significantly repress
luciferase activity. However, GAL4-COUP-TF2(117-414) significantly repressed transcription 3.9 ± 0.1-fold (Fig.
6), and co-expression of FOG-2 markedly
increased repression to 13.5 ± 1.1-fold (p < 0.0001, GAL4-COUP-TF2(117-414) vector versus FOG-2).
GAL4-COUP-TF2(117-335) did not significantly repress luciferase
activity, and co-expression of FOG-2 did not increase repression.
Previous studies suggested that H10 of COUP-TF2 is required for
COUP-TF2-dependent repression (30, 31, 33). In support of
this, we found that the COUP-TF2 (117-414 MUT) H10 triple
mutant did not repress luciferase activity, and co-expression of FOG-2
did not augment this repression. Western blotting confirmed expression
of each GAL4 fusion protein (data not shown). These results demonstrate
that COUP-TF2 can recruit FOG-2 as a corepressor protein.
COUP-TF2 Synergistically Activates the ANF Promoter with
GATA4--
COUP-TF2 is required for normal atrial development (27). To
further investigate the role of COUP-TF2 in atrium-specific transcription, we examined the effect of COUP-TF2 on a rat ANF ( COUP-TF2 Is Necessary for FOG-2 Repression of
GATA4-E215K-dependent Transcription--
Finally, we
tested our hypothesis that FOG-2 could repress
COUP-TF2-dependent transcription of a cardiac-specific
promoter. As demonstrated previously (9, 22), co-transfection of FOG-2 repressed GATA4-dependent activation of the ANF promoter by
5.2-fold (Fig. 8A), whereas
FOG-2 had no effect on the GATA4-E215K mutant (0.71-fold repression),
which fails to interact with FOG-2 (22). FOG-2 repressed the
GATA4-COUP-TF2-dependent synergistic activation of the
ANF-luciferase reporter by 4.5-fold (155 ± 8.5 versus
34 ± 5.7; p < 0.0001; Fig. 8B). This
finding showed that FOG-2 repressed ANF promoter activity; however it
was not clear whether FOG-2 caused this repression by its interaction
with GATA4, COUP-TF2, or both. To separate the effects of FOG-2 on
COUP-TF2 from the effects of FOG-2 on GATA4, we used the GATA4-E215K
mutant, which does not interact with FOG-2 (22). In the presence of
COUP-TF2, FOG-2 repressed activation of ANF-luciferase by GATA4-E215K
by 3.2-fold (197 ± 8.1 versus 62 ± 8.5;
p < 0.0001; Fig. 8B). These results clearly
demonstrated that FOG-2 can serve as a corepressor protein for COUP-TF2
on a cardiac-specific promoter.
In screening for novel interacting partners of FOG-2, the fifth
and sixth zinc fingers of FOG-2 were used as bait because they are both
CCHC zinc fingers that interact with the amino CCCC zinc finger of
GATA4 (14). Our yeast-two hybrid screen isolated cDNA clones
encoding the ligand-binding domains of both COUP-TF2 and COUP-TF3,
which was unexpected because crystallography has not demonstrated a
zinc finger within this region of nuclear receptors (30, 33). Because
FOG-2 could not bind COUP-TF2 by a finger-finger interaction, we
compared which FOG-2 zinc fingers bound GATA4 and COUP-TF2. In
agreement with previously published studies (8, 14), GATA4 was retained
well by GST-FOG-2 proteins encoding zinc finger 6, zinc fingers 7 and
8, and zinc fingers 1-4. COUP-TF2 was retained strongly by fingers 7 and 8, followed by zinc fingers 5 and 6, and COUP-TF2 was retained
weakly by finger 6 alone and fingers 1-4 (Fig. 2). If COUP-TF2
interacted with the same zinc fingers as GATA4, with the same
affinities, then we would have expected the same pattern of binding by
GST-FOG-2 proteins. Our finding of distinct patterns of zinc finger
interaction by COUP-TF2 and GATA4 is further supported by our mammalian
two-hybrid analysis, which found that mutation of zinc finger 5 had a
greater effect on VP16-COUP-TF2(117-414) binding than mutation of
finger 6 (Fig. 3). These results demonstrate that GATA4 interacts with
zinc finger 6 more strongly than with zinc finger 5, whereas COUP-TF2
clearly favors zinc finger 5 more than zinc finger 6. Whereas both
GATA4 and COUP-TF2 can bind both zinc fingers 5 and 6, their relative affinity for different FOG-2 zinc fingers suggests the possibility that
FOG-2 could interact with both proteins simultaneously.
The nuclear receptor ligand-binding domain serves as a molecular switch
allowing ligand-induced conversion from transcriptional repression to
activation (29). Ligand-binding domains are compact structures with a
conserved architecture shaped by 10 helices forming a hydrophobic core
tethered to the ligand-dependent transactivation domain,
AF2, by the tenth helix, H10 (33). H10 is also a protein interaction
surface, forming most of the interface for nuclear receptor dimers.
Mutation of three leucine residues within the H10 of COUP-TF2 prevented
FOG-2 binding (Fig. 4). This clearly demonstrates that FOG-2 interacts
with the carboxyl terminus of COUP-TF2, a region that is also bound by
other corepressor proteins. In addition to nuclear receptor-corepressor
(N-Cor) and silencing mediator and thyroid hormone receptor (SMRT)
(35), the COUP-TF2 ligand-binding domain binds Alien (36) and the
nuclear receptor-corepressor variant RIP13 COUP-TF proteins repress transcription by binding directly to chromatin
as a homodimer or heterodimer (40) (active repression) or after forming
a dimer with a different member of the nuclear receptor family
(transrepression) (25). Sequestration of coactivators into
non-DNA-binding complexes by the COUP-TF proteins has also been
proposed, but this mechanism of repression has been disputed (31).
Active repression by COUP-TF1 requires the entire ligand-binding domain. Removal of H11, H12, and AF2 results in a loss of
COUP-TF1-mediated repression, suggesting their role in binding
corepressor proteins (35). Using GAL4-COUP-TF2 fusion proteins, we have
demonstrated that deletion of the carboxyl terminus of COUP-TF2
abolishes active repression, FOG-2 interaction, and FOG-2-mediated
repression. Within the ligand-binding domain, mutations of H1
disrupt binding by nuclear receptor-corepressor and silencing mediator
and thyroid hormone receptor; however, H1 mutation likely changes
the overall ligand-binding domain structure (33). The crystal structure of nuclear receptors has shown that H10 is an exposed protein-protein interaction surface (30). Mutation of the leucine residues performed in
this study likely altered the conformation of H10 on the ligand-binding domain (33). We have demonstrated that this mutation decreases active
repression by GAL4-COUP-TF2, suggesting that this site may also serve
as a corepressor binding site. We found that mutation of H10 prevents
FOG-2 binding, such that FOG-2 can no longer serve as a corepressor for
COUP-TF2. Taken together our results are consistent with a model in
which FOG-2 interacts with H10 as well as regions affected by H10 such
as AF2, and that the FOG-2 binding site is also used by other
corepressor proteins.
Although COUP-TF proteins are generally considered to be repressors of
transcription, there are examples of COUP-TF-dependent transcriptional activation (41, 42). Direct promoter binding by COUP-TF
is required for complete induction of phosphoenolpyruvate carboxykinase
gene transcription by glucocorticoids (43, 44). COUP-TF1 binds
Sp1 to activate the NFGI-A gene expression (45). The molecular
mechanism of COUP-TF-mediated activation includes binding of steroid
receptor activator 1 and p300 coactivator proteins to the carboxyl
terminus of COUP-TF1 (45). To our knowledge, we now report for the
first time the synergistic activation of the cardiac-specific ANF
promoter by GATA4 and COUP-TF2. There are several potential mechanisms
that may explain the synergistic activation of the ANF promoter by
COUP-TF2 and GATA4, and this is the subject of active work.
FOG-2 repressed COUP-TF2-dependent synergistic activation
of the ANF promoter by GATA4. This result left open the possibility that FOG-2 repressed the synergistic activation solely by binding GATA4. To separate the ability of FOG-2 to repress
GATA4-dependent transcription from its effects on COUP-TF2,
we used the GATA4-E215K mutant, which does not interact with FOG-2
(22). We show that FOG-2 can repress GATA4-dependent but
not GATA4-E215K-dependent transcriptional activation of the
ANF promoter. However, FOG-2 repressed transcriptional activation by
GATA4-E215K in the presence of COUP-TF2, which demonstrates that FOG-2
can serve as a corepressor protein for COUP-TF2 on a cardiac-specific
promoter. It is noteworthy that FOG-2 repression of
GATA4-E215K/COUP-TF2 transcription was not complete. Crispino et
al. (46) created mice harboring the GATA4-V217G mutation
(numbering differs from the published report, reflecting mouse GATA4
sequence in GenBank accession number NP 032118), which produces a
GATA4 mutant that does not interact with FOG (46). Mice homozygous for
this mutation resembled the FOG-2-deficient mice, yet there were
differences in eHAND expression and orientation of the outflow
tracts. The incomplete phenocopy of the GATA4-V217G knock-in and the
FOG-2 knock-out may reflect an interaction of GATA4 with a different
FOG protein (46), yet our results raise the possibility that FOG-2 may
be interacting with COUP-TF2 in concert with GATA4.
In summary, we have demonstrated the interaction of FOG-2 with a
transcriptional regulator other than the GATA proteins. The physiologic
importance of this interaction is underscored by the finding that
FOG-2-null and COUP-TF2-null mice have defects related to
mesenchymal-epithelial and -endothelial interactions, which are
important for heart and blood vessel formation. We have demonstrated preferential binding of different zinc fingers by COUP-TF2 and GATA4.
COUP-TF2 can utilize FOG-2 as a corepressor protein to down-regulate
transcription from both a heterologous promoter and a cardiac-specific
promoter. Taken together, these results suggest that FOG-2 interacts
with multiple cardiac transcription factors to regulate the complex
program of cardiac morphogenesis.
, glucocorticoid receptor, and peroxisome proliferating antigen
receptor
, which are related to the COUP-TF proteins. Full-length
FOG-2 markedly enhanced transcriptional repression by
GAL4-COUP-TF2(117-414), but not by a COUP-TF2 repression domain mutant. Moreover, FOG-2 repressed COUP-TF2dependent synergistic activation of the atrial natriuretic factor promoter by both GATA4 and
the FOG-2-independent mutant GATA4-E215K. Taken together, these
findings suggest that FOG-2 functions as a corepressor for both
GATA and COUP-TF proteins.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
COUP-TF2 interacts with FOG-2
(aa 151-475) was made by cloning the
BamHI/SalI fragment of the PPAR
cDNA into
pACT2. Mouse RXR
was cloned by reverse transcription-polymerase
chain reaction, and then the NcoI fragment was used to clone
pACT2-RXR
(aa 204-446). PSG5-RXR
was kindly provided by Soo Jong
Um (Sejong University, Seoul, Korea). pACT2-GR-(aa 393-783) was
cloned using reverse transcription-polymerase chain reaction with
custom-designed oligonucleotide primers. GATA4 and GATA4-E215K cloned
into pcDNA3 were used as described previously (22).
-galactosidase staining were isolated and sequenced using standard
techniques. For interaction assays, a clone harboring the bait plasmid
was transformed with pACT2, pACT2-COUP-TF2(aa 117-414),
pACT2-COUP-TF3(aa 162-390), pACT2-RXR
-(aa 204-466),
pACT2-PPAR
-(aa 151-475), or pACT2-GR-(aa 393-783). For each
transformation, three separate clones were isolated on selection plates
lacking tryptophan and leucine.
-Galactosidase activity was measured
using a liquid assay, as described previously (28).
, GATA4, and luciferase were expressed and labeled with
[35S]methionine (Amersham Pharmacia Biotech) by using the
TnT T7 Coupled Reticulocyte System (Promega). Labeled proteins were
mixed with glutathione-Sepharose 4B (Amersham Pharmacia Biotech) beads coated with GST fusion proteins in 50 mM NaCl, 0.1%
Nonidet P-40, 1 mg/ml bovine serum albumin, 0.25%
-mercaptoethanol,
and 10 µM ZnSO4 for 30 min. The beads were
washed in phosphate-buffered saline and 0.1% Nonidet P-40. The
proteins were eluted with sample buffer and separated by 15%
SDS-polyacrylamide gel electrophoresis, and the dried gel was used for
autoradiography with Kodak BioMax MR film.
-galactosidase served as a control for transfectional efficiency. At
24-48 h after transfection, cellular extracts were harvested in
Reporter Lysis Buffer (Promega), and luciferase activity was measured
on a luminometer (Autolumat 953; EG&G, Gaithersburg, MD) using the
Promega luciferase system;
-galactosidase activity was measured by
conversion of o-nitrophenyl
-D-galactopyranoside. Each sample was performed in
triplicate, and each experiment was repeated at least three times.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-galactosidase activity. Clone 3 encoded
part of the DNA-binding domain and the ligand-binding domain of
COUP-TF2 (nucleotides 496-1560, aa 117-414), whereas clone 11 encoded
the putative ligand-binding domain of COUP-TF3 (nucleotides 689-1734,
aa 162-390) (Fig. 1A).
Northern analysis confirmed co-expression of FOG-2 and COUP-TF2 in the
adult mouse heart, and in situ hybridization of day 13.5 mouse embryos confirmed co-expression in the developing atria and
ventricles (data not shown).

View larger version (38K):
[in a new window]
Fig. 1.
A, diagram of COUP-TF2 and COUP-TF3
protein structure. The arrow and number indicate
the first amino acid of each protein expressed by the library plasmid.
The cartoons demonstrate the locations of the DNA-binding domain
(DBD) and the ligand-binding domain (LBD).
B, full-length COUP-TF2 co-immunoprecipitated with FOG-2.
Extracts from COS-7 cells transfected with expression plasmids for
FOG-2 (left two lanes), COUP-TF2 (middle two
lanes), and FOG-2/COUP-TF2 (right two lanes) were
subjected to immunoprecipitation (IP) with either preimmune
(P) or immune (I) FOG-2 antisera. The proteins
were separated by SDS-polyacrylamide gel electrophoresis and blotted on
nitrocellulose. The membrane was then cut, and the lower half was
probed by Western blotting (WB) with the anti-X-press
antibody to detect recombinant COUP-TF2, whereas the upper half was
probed with rabbit anti-FOG-2 antisera. A representative of four
experiments is shown, demonstrating that COUP-TF2 was isolated only by
co-immunoprecipitation with FOG-2.

View larger version (51K):
[in a new window]
Fig. 2.
COUP-TF2 and GATA4 associate with the FOG-2
zinc fingers in vitro. Twenty percent of the
[35S]methionine-labeled in vitro translation
product used for binding is shown in the first lane. After
the radiolabeled proteins had been incubated with immobilized GST or
GST-FOG-2 fusion proteins, the beads were washed, and the bound input
was eluted with sample buffer and subjected to 15% SDS-polyacrylamide
gel electrophoresis. COUP-TF2 was selectively retained by GST-FOG-2
F7-8 and F5-6 to a greater extent than F6, F1-4, amino terminus
(N-term), or GST. GATA4 was retained by all of the GST-FOG-2
proteins that included zinc fingers. The GST-FOG-2 fusion proteins did
not retain luciferase. Coomassie Blue staining of the gel demonstrated
strong expression of each GST protein (data not shown). A
representative of three experiments is shown.

View larger version (10K):
[in a new window]
Fig. 3.
The interaction of COUP-TF2 with FOG-2
requires FOG-2 zinc fingers. Site-directed polymerase chain
reaction-based mutagenesis was used to introduce selective mutations of
cysteine residues in FOG-2(aa 497-831) required for zinc finger
formation. The mutant constructs were cloned into pM vector for
expression as fusion proteins with the GAL4 DNA-binding domain. These
plasmids were transiently transfected into NIH 3T3 cells with a plasmid
encoding VP16-COUP-TF2(117-414) and a GAL4-responsive SV40 promoter
luciferase reporter plasmid. The mean ± S.E. fold activation for
each pM-FOG-2 construct co-transfected with pVP16-COUP-TF2(117-414)
was normalized to the activity of the same plasmid co-transfected with
pVP16. GAL4-FOG-2-F5F6 interacted with VP16-COUP-TF2(117-414) to a
greater degree than the GAL4-FOG-2 zinc finger 6 mutant
(F5M6) and the zinc finger 5 mutant (M5F6).
Mutation of both zinc fingers abolished binding, which demonstrates
that FOG-2 zinc fingers are required for COUP-TF2 interaction. Results
from three experiments performed in triplicate are shown. *, a
statistically significant (p < 0.05) interaction
compared with GAL4.

View larger version (11K):
[in a new window]
Fig. 4.
GAL4-FOG-2(aa 497-831) interacts with
VP16-COUP-TF2 in NIH 3T3 cells. The GAL4-SV40 promoter luciferase
reporter plasmid was co-transfected into NIH 3T3 cells with pM-FOG-2(aa
497-831) and pVP16 plasmids encoding COUP-TF2 fusion proteins. The
mean ± S.E. fold activation relative to VP16 from three
experiments performed in triplicate is shown. *, a statistically
significant (p < 0.05) difference in comparison with
VP16 alone.
, were selectively retained by GST-FOG-2-F5-6 compared with GST
alone (Fig. 5A). Next, we used
a yeast two-hybrid assay to test the interaction of FOG-2 with the
ligand-binding domain of several nuclear hormone receptor proteins
fused to the GAL4 transcriptional activation domain. A liquid
-galactosidase assay provided a semiquantitative analysis of
interaction in the AH109 yeast strain, which harbors a GAL4-responsive
-galactosidase gene. GAL4-FOG-2(aa 497-831) selectively bound the
ligand-binding domains of COUP-TF2 and COUP-TF3, but not with
the ligand-binding domains of RXR
, PPAR
, and GR (Fig.
5B). These results clearly demonstrate that FOG-2
selectively interacts with the COUP-TF family of orphan nuclear hormone
receptors.

View larger version (33K):
[in a new window]
Fig. 5.
A, FOG-2 associates with COUP-TF1 and
COUP-TF3 in vitro. Twenty percent of the translation product
used for the binding assay was loaded on the left lane.
GST-FOG-2-F5-6 selectively retained GATA4, COUP-TF1, and COUP-TF3 to a
much greater extent than GST alone. B, FOG-2 interacts
selectively with the ligand-binding domains of COUP-TF2 and COUP-TF3 in
yeast. An AH109 culture transformed with pGAL4-BD-CAM-FOG-2(aa
497-831) was transformed with pACT2 plasmids encoding GAL4
transcriptional-activating domain fusion proteins with the
ligand-binding domains of COUP-TF2, COUP-TF3, RXR
, GR, and PPAR-
.
The liquid
-galactosidase activity for each sample normalized to
vector alone is shown. *, constructs that produced significantly more
-galactosidase (p < 0.05) compared with vector
alone. The mean ± S.E. from three experiments performed in
triplicate is shown.

View larger version (12K):
[in a new window]
Fig. 6.
COUP-TF2 uses FOG-2 as a corepressor
protein. The GAL4-regulated SV40 promoter luciferase reporter
plasmid has a high basal luciferase activity in 293 cells. We
co-transfected plasmids encoding GAL4-COUP-TF2 proteins, and the
reduction in luciferase activity relative to GAL4 alone is reported as
fold repression. In the absence of FOG-2 (
), only
GAL4-COUP-TF2(117-414) significantly repressed luciferase activity.
Removal of the carboxyl terminus and mutation of H10 resulted in a loss
of repression activity. Co-expression of FOG-2 (
) with
GAL4-COUP-TF2(117-414) markedly increased repression. **,
constructs that caused significant repression (p < 0.0001) compared with GAL4 alone. The mean ± S.E. from three
experiments is shown.
638
to +62)-promoter luciferase reporter plasmid (kindly provided by
Kenneth R. Chien (34)). We found that GATA4 produced a significant activation of the ANF-luciferase reporter plasmid (mean ± S.E., 21.1 ± 1.4-fold; p = 0.028); in contrast,
His-COUP-TF2 alone had little effect on ANF promoter activity (Fig.
7). Co-expression of full-length
His-COUP-TF2 with GATA4 produced a synergistic dose-dependent activation of the ANF-luciferase reporter
plasmid that was highly significant (up to 300-fold). The
carboxyl-terminal deletion mutant His-COUP-TF2(1-335) did not
influence GATA-dependent transcription (data not
shown).

View larger version (9K):
[in a new window]
Fig. 7.
COUP-TF2 increases the transcriptional
activity of GATA4. CV-1 cells were co-transfected with the
ANF(
638 to +62) luciferase reporter plasmid (34) and
pcDNA3-
-galactosidase to correct for differences in transfection
efficiency. In the absence of GATA4 (
), COUP-TF2 did not
significantly activate the ANF luciferase reporter plasmid. In the
presence of GATA4 (
), increasing amounts of
pcDNA3.1/His-COUP-TF2 expression plasmid produced a marked
induction of luciferase activity. For each category, the corrected
luciferase activity was normalized to the average luciferase activity
of the reporter plasmids co-transfected with vector alone. *,
p < 0.05 compared with vector alone; **,
p < 0.0001 compared with vector alone.

View larger version (11K):
[in a new window]
Fig. 8.
A, FOG-2 does not repress
GATA4-E215K-dependent transcription in CV-1 cells.
Transient transfection in CV-1 cells was performed as described
previously. In the absence of COUP-TF2, FOG-2 repressed
GATA4-dependent (lane 4 versus lane
3) transcription of the ANF promoter but not
GATA4-E215K-dependent (lane 6 versus lane
5) transcription of the ANF promoter. B, FOG-2
represses COUP-TF2-dependent synergistic activation of
transcription by GATA4-E215K. 100 ng of
pcDNA3.1/His-COUP-TF2(1-414) was co-transfected with each sample.
Co-expression of COUP-TF2 with GATA4 produced a 7.1-fold increase in
ANF-luciferase activity, and an 11.2-fold increase was produced with
GATA4-E215K. FOG-2 significantly repressed the
COUP-TF2-dependent synergistic luciferase activity for both
GATA4 and GATA4-E215K.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1 (37) corepressor
proteins. In the brain, COUP-TF1 is co-expressed with the zinc finger
proteins CTIP1 and CTIP2, which bind COUP-TF1 and serve as corepressor
proteins (38). We have demonstrated that FOG-2 selectively interacts
with the ligand-binding domains of all three COUP-TF proteins, but not with RXR
, PPAR
, or GR (Fig. 5). Besides differences in primary sequence (39), the lack of the second helix in the COUP-TF proteins (31) may alter the ligand-binding domain sufficiently to explain their
selective interaction with FOG-2. Alien also selectively interacts with
some, but not all, nuclear hormone receptors (36). The selective use of
tissue-restricted corepressor proteins may be a mechanism by which
widely expressed DNA-binding proteins can cause organ-specific transcription.
| |
ACKNOWLEDGEMENTS |
|---|
We greatly appreciate the support provided by members of the Leiden laboratory and their careful review of and suggestions on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by Mentored Clinical Scientist Development Award K08 HL03667-01A1 and Grant R01 HL54592-06 from the National Institutes of Health and Beginning Grant-in-Aid 0060313T from the American Heart Association.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Cardiovascular Biology Laboratory, Harvard School of Public Health, 677 Huntington Ave., Boston, MA 02115. Tel.: 617-432-4994; Fax: 617-432-2980; E-mail: huggins@cvlab.harvard.edu.
Published, JBC Papers in Press, May 29, 2001, DOI 10.1074/jbc.M103577200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
FOG, Friend of GATA;
COUP-TF, chicken ovalbumin upstream promoter-transcription factor;
ANF, atrial natriuretic factor;
RXR
, retinoid X receptor
;
GR, glucocorticoid receptor;
PPAR
, peroxisome proliferating antigen
receptor
;
CCCC, CCHC, and CCHH, zinc finger subtypes in which a
zinc atom is coordinated by cysteine (C) or histidine (H) side chains;
aa, amino acid(s);
GST, glutathione S-transferase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Collingwood, T. N., Urnov, F. D., and Wolffe, A. P. (1999) J. Mol. Endocrinol. 23, 255-275 |
| 2. | Tsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., and Orkin, S. H. (1997) Cell 90, 109-119 |
| 3. | Tsang, A. P., Fujiwara, Y., Hom, D. B., and Orkin, S. H. (1998) Genes Dev. 12, 1176-1188 |
| 4. | Deconinck, A. E., Mead, P. E., Tevosian, S. G., Crispino, J. D., Katz, S. G., Zon, L. I., and Orkin, S. H. (2000) Development (Camb.) 127, 2031-2040 |
| 5. | Tevosian, S. G., Deconinck, A. E., Tanaka, M., Schinke, M., Litovsky, S. H., Izumo, S., Fujiwara, Y., and Orkin, S. H. (2000) Cell 101, 729-739 |
| 6. | Svensson, E. C., Huggins, G. S., Lin, H., Clendenin, C., Jiang, F., Tufts, R., Dardik, F. B., and Leiden, J. M. (2000) Nat. Genet. 25, 353-356 |
| 7. | Matthews, J. M., Kowalski, K., Liew, C. K., Sharpe, B. K., Fox, A. H., Crossley, M., and MacKay, J. P. (2000) Eur. J. Biochem. 267, 1030-1038 |
| 8. | Fox, A. H., Liew, C., Holmes, M., Kowalski, K., Mackay, J., and Crossley, M. (1999) EMBO J. 18, 2812-2822 |
| 9. | Svensson, E. C., Tufts, R. L., Polk, C. E., and Leiden, J. M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 956-961 |
| 10. | Tevosian, S. G., Deconinck, A. E., Cantor, A. B., Rieff, H. I., Fujiwara, Y., Corfas, G., and Orkin, S. H. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 950-955 |
| 11. | Lu, J. R., McKinsey, T. A., Xu, H., Wang, D. Z., Richardson, J. A., and Olson, E. N. (1999) Mol. Cell. Biol. 19, 4495-4502 |
| 12. | Durocher, D., Charron, F., Warren, R., Schwartz, R. J., and Nemer, M. (1997) EMBO J. 16, 5687-5696 |
| 13. | Lee, Y., Shioi, T., Kasahara, H., Jobe, S. M., Wiese, R. J., Markham, B. E., and Izumo, S. (1998) Mol. Cell. Biol. 18, 3120-3129 |
| 14. | Fox, A. H., Kowalski, K., King, G. F., Mackay, J. P., and Crossley, M. (1998) J. Biol. Chem. 273, 33595-33603 |
| 15. | Cheng, G., Hagen, T. P., Dawson, M. L., Barnes, K. V., and Menick, D. R. (1999) J. Biol. Chem. 274, 12819-12826 |
| 16. | Ip, H. S., Wilson, D. B., Heikinheimo, M., Tang, Z., Ting, C. N., Simon, M. C., Leiden, J. M., and Parmacek, M. S. (1994) Mol. Cell. Biol. 14, 7517-7526 |
| 17. | Lien, C. L., Wu, C., Mercer, B., Webb, R., Richardson, J. A., and Olson, E. N. (1999) Development (Camb.) 126, 75-84 |
| 18. | Searcy, R. D., Vincent, E. B., Liberatore, C. M., and Yutzey, K. E. (1998) Development (Camb.) 125, 4461-4470 |
| 19. | Rosoff, M. L., and Nathanson, N. M. (1998) J. Biol. Chem. 273, 9124-9129 |
| 20. | Kuo, C. T., Morrisey, E. E., Anandappa, R., Sigrist, K., Lu, M. M., Parmacek, M. S., Soudais, C., and Leiden, J. M. (1997) Genes Dev. 11, 1048-1060 |
| 21. | Molkentin, J. D., Lin, Q., Duncan, S. A., and Olson, E. N. (1997) Genes Dev. 11, 1061-1072 |
| 22. | Svensson, E. C., Huggins, G. S., Dardik, F. B., Polk, C. E., and Leiden, J. M. (2000) J. Biol. Chem. 275, 20762-20769 |
| 23. | Fossett, N., Zhang, Q., Gajewski, K., Choi, C. Y., Kim, Y., and Schulz, R. A. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 7348-7353 |
| 24. | Wang, L. H., Tsai, S. Y., Cook, R. G., Beattie, W. G., Tsai, M. J., and O'Malley, B. W. (1989) Nature 340, 163-166 |
| 25. | Tsai, S. Y., and Tsai, M. J. (1997) Endocr. Rev. 18, 229-240 |
| 26. | Jonk, L. J., de Jonge, M. E., Pals, C. E., Wissink, S., Vervaart, J. M., Schoorlemmer, J., and Kruijer, W. (1994) Mech. Dev. 47, 81-97 |
| 27. | Pereira, F. A., Qiu, Y., Zhou, G., Tsai, M. J., and Tsai, S. Y. (1999) Genes Dev. 13, 1037-1049 |
| 28. | Huggins, G. S., Chin, M. T., Sibinga, N. E., Lee, S. L., Haber, E., and Lee, M. E. (1999) J. Biol. Chem. 274, 28690-28696 |
| 29. | Perlmann, T., and Evans, R. M. (1997) Cell 90, 391-397 |
| 30. | Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., and Moras, D. (1995) Nature 375, 377-382 |
| 31. | Achatz, G., Holzl, B., Speckmayer, R., Hauser, C., Sandhofer, F., and Paulweber, B. (1997) Mol. Cell. Biol. 17, 4914-4932 |
| 32. | Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., and Lazar, M. A. (2000) Genes Dev. 14, 45-54 |
| 33. | Wurtz, J. M., Bourguet, W., Renaud, J. P., Vivat, V., Chambon, P., Moras, D., and Gronemeyer, H. (1996) Nat. Struct. Biol. 3, 87-94 |
| 34. | Knowlton, K. U., Baracchini, E., Ross, R. S., Harris, A. N., Henderson, S. A., Evans, S. M., Glembotski, C. C., and Chien, K. R. (1991) J. Biol. Chem. 266, 7759-7768 |
| 35. | Shibata, H., Nawaz, Z., Tsai, S. Y., O'Malley, B. W., and Tsai, M. J. (1997) Mol. Endocrinol. 11, 714-724 |
| 36. | Dressel, U., Thormeyer, D., Altincicek, B., Paululat, A., Eggert, M., Schneider, S., Tenbaum, S. P., Renkawitz, R., and Baniahmad, A. (1999) Mol. Cell. Biol. 19, 3383-3394 |
| 37. | Bailey, P. J., Dowhan, D. H., Franke, K., Burke, L. J., Downes, M., and Muscat, G. E. (1997) J. Steroid Biochem. Mol. Biol. 63, 165-174 |
| 38. | Avram, D., Fields, A., Pretty On Top, K., Nevrivy, D. J., Ishmael, J. E., and Leid, M. (2000) J. Biol. Chem. 275, 10315-10322 |
| 39. | Qiu, Y., Krishnan, V., Pereira, F. A., Tsai, S. Y., and Tsai, M. J. (1996) J. Steroid Biochem. Mol. Biol. 56, 81-85 |
| 40. | Avram, D., Ishmael, J. E., Nevrivy, D. J., Peterson, V. J., Lee, S. H., Dowell, P., and Leid, M. (1999) J. Biol. Chem. 274, 14331-14336 |
| 41. | Power, S. C., and Cereghini, S. (1996) Mol. Cell. Biol. 16, 778-791 |
| 42. | Lazennec, G., Kern, L., Valotaire, Y., and Salbert, G. (1997) Mol. Cell. Biol. 17, 5053-5066 |
| 43. | Scott, D. K., Mitchell, J. A., and Granner, D. K. (1996) J. Biol. Chem. 271, 31909-31914 |
| 44. | Hall, R. K., Sladek, F. M., and Granner, D. K. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 412-416 |
| 45. | Pipaon, C., Tsai, S. Y., and Tsai, M. J. (1999) Mol. Cell. Biol. 19, 2734-2745 |
| 46. | Crispino, J. D., Lodish, M. B., Thurberg, B. L., Litovsky, S. H., Collins, T., Molkentin, J. D., and Orkin, S. H. (2001) Genes Dev. 15, 839-844 |
This article has been cited by other articles:
![]() |
R. D. Clugston, W. Zhang, and J. J. Greer Gene expression in the developing diaphragm: significance for congenital diaphragmatic hernia Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L665 - L675. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsushita, S. Sasaki, Y. Kashiwabara, K. Nagayama, K. Ohba, H. Iwaki, H. Misawa, K. Ishizuka, and H. Nakamura Essential Role of GATA2 in the Negative Regulation of Thyrotropin {beta} Gene by Thyroid Hormone and Its Receptors Mol. Endocrinol., April 1, 2007; 21(4): 865 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Ackerman, J. Wang, L. Luo, Y. Fujiwara, S. H. Orkin, and D. R. Beier Gata4 Is Necessary for Normal Pulmonary Lobar Development Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Gardner, S. Chen, D. J. Glenn, and C. L. Grigsby Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension Hypertension, March 1, 2007; 49(3): 419 - 426. [Full Text] [PDF] |
||||
![]() |
A. Hamik, B. Wang, and M. K. Jain Transcriptional Regulators of Angiogenesis Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1936 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Lin, A. E. Roche, J. Wilk, and E. C. Svensson The N Termini of Friend of GATA (FOG) Proteins Define a Novel Transcriptional Repression Motif and a Superfamily of Transcriptional Repressors J. Biol. Chem., December 31, 2004; 279(53): 55017 - 55023. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Clabby, T. A. Robison, H. F. Quigley, D. B. Wilson, and D. P. Kelly Retinoid X Receptor alpha Represses GATA-4-mediated Transcription via a Retinoid-dependent Interaction with the Cardiac-enriched Repressor FOG-2 J. Biol. Chem., February 14, 2003; 278(8): 5760 - 5767. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Reese, T. Mikawa, and D. M. Bader Development of the Coronary Vessel System Circ. Res., November 1, 2002; 91(9): 761 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Robert, J. J. Tremblay, and R. S. Viger Friend of GATA (FOG)-1 and FOG-2 Differentially Repress the GATA-Dependent Activity of Multiple Gonadal Promoters Endocrinology, October 1, 2002; 143(10): 3963 - 3973. [Abstract] [Full Text] [PDF] |
||||